Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Advanced Enzyme Technologies Ltd (ADVENZYMES) Price & Analysis

ADVENZYMES Stock Chart & Stats

₹262.95-₹1.45(-0.55%)
At close: 4:00 PM EDT
INR 250INR 275INR 300INR 3253 Aug17 Aug31 Aug15 Sep28 Sep12 Oct26 Oct
Day’s Range
INR 259.75 - INR 266.10
52-Week Range
INR 247.10 - INR 419.80
Previous Close
INR 264.40
Volume
535.87K
Average Volume (3M)
9,801
Market Cap
INR 29.44B
Enterprise Value
INR 22.36B
Total Cash (Recent Filing)
INR 7.05B
Total Debt (Recent Filing)
INR 0
Price to Earnings (P/E)
17.8
Beta
1.12
Next Earnings
Feb 08, 2027
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
0.51%

Bulls Say, Bears Say

Bulls Say

Balance Sheet Strength

Very low leverage and steadily rising equity give the company substantial financial flexibility and low solvency risk. This reduces dependence on borrowing to fund operations or growth, helping preserve resilience and strategic options through the next several quarters.

Cash Generation

Consistently positive operating cash flow that exceeds net income indicates strong earnings quality and supports internally funded operations. Solid free cash flow further enables reinvestment and financial flexibility, although its year-to-year growth varies.

Profitable Revenue Growth

Revenue has grown steadily and reached about ₹7.46B in FY2026 after a muted FY2025, while net margins generally remain above 20%. That combination indicates a profitable operating model with capacity to convert renewed demand into earnings over coming quarters.

Bears Say

Margin Normalization

Net and operating margins remain healthy but have compressed from FY2021–FY2022 peaks. This normalization may reduce incremental earnings from each unit of revenue and could constrain profit expansion unless pricing, mix, or costs improve.

Uneven Free Cash Flow Growth

Free cash flow conversion to net income is below 1.0 and free cash flow growth has been uneven, including dips in FY2022 and softer growth in FY2024–FY2025. This can make internally generated funding less predictable despite strong underlying cash generation.

Moderating Return On Equity

Returns on equity are described as good but not consistently accelerating, with moderation after earlier peaks. This suggests the company is not steadily improving capital productivity, which may limit the pace at which shareholder returns compound even with low leverage.

Advanced Enzyme Technologies Ltd News

ADVENZYMES FAQ

What was Advanced Enzyme Technologies Ltd’s price range in the past 12 months?
Advanced Enzyme Technologies Ltd lowest stock price was ₹247.10 and its highest was ₹419.80 in the past 12 months.
What is Advanced Enzyme Technologies Ltd’s market cap?
Advanced Enzyme Technologies Ltd’s market cap is ₹29.44B.
When is Advanced Enzyme Technologies Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Advanced Enzyme Technologies Ltd’s earnings last quarter?
Advanced Enzyme Technologies Ltd released its earnings results on Aug 08, 2026. The company reported ₹3.313 earnings per share for the quarter.
Is Advanced Enzyme Technologies Ltd overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Advanced Enzyme Technologies Ltd pay dividends?
Advanced Enzyme Technologies Ltd pays a Quarterly dividend of ₹1.35 which represents an annual dividend yield of 0.51%. See more information on Advanced Enzyme Technologies Ltd dividends here
What is Advanced Enzyme Technologies Ltd’s EPS estimate?
Advanced Enzyme Technologies Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Advanced Enzyme Technologies Ltd have?
Advanced Enzyme Technologies Ltd has 111,976,150 shares outstanding.
What happened to Advanced Enzyme Technologies Ltd’s price movement after its last earnings report?
Advanced Enzyme Technologies Ltd reported an EPS of ₹3.313 in its last earnings report. Following the earnings report the stock price went up 6.825%.
Which hedge fund is a major shareholder of Advanced Enzyme Technologies Ltd?
Currently, no hedge funds are holding shares in IN:ADVENZYMES
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology